AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Hannover Rueck SE

Quarterly Report Nov 4, 2021

197_10-q_2021-11-04_a7c29bf4-f56a-41d4-b2de-b4b9985735cc.pdf

Quarterly Report

Open in Viewer

Opens in native device viewer

Quarterly statement as at 30 September 2021

Key figures

in EUR million 2021 2020
1.1.– 1.7.– +/– 1.1.– +/– 1.7.– 1.1.– 31.12. ¹
30.6. 30.9. previous
year
30.9. previous
year
30.9. 30.9.
Results
Gross written premium 14,464.6 7,155.0 +16.4% 21,619.6 +12.0% 6,148.8 19,294.9
Net premium earned 11,515.3 6,118.6 +13.4% 17,633.9 +11.8% 5,393.6 15,771.7
Net underwriting result ² 124.3 (187.0) (62.8) (108.9) (439.2)
Net investment income 865.8 491.1 +25.3% 1,356.9 +14.5% 391.9 1,185.0
Operating profit (EBIT) 956.1 324.5 -18.7% 1,280.6 +41.8% 399.3 902.9
Group net income 670.6 185.4 -30.2% 855.9 +28.2% 265.5 667.8
Balance sheet
Policyholders' surplus 14,859.2 15,238.2 +8.3% 14,071.0
Equity attributable to shareholders of
Hannover Rück SE
11,050.6 11,409.0 +3.8% 10,995.0
Non-controlling interests 831.7 851.7 +0.9% 844.4
Hybrid capital 2,976.9 2,977.5 +33.4% 2,231.6
Investments (excl. Funds withheld by
ceding companies)
52,847.7 55,029.9 +12.3% 49,001.6
Total assets 78,099.2 81,788.2 +14.5% 71,437.5
Share
Earnings per share (basic and diluted)
in EUR
5.56 1.54 -30.2% 7.10 +28.2% 2.20 5.54
Book value per share in EUR 91.63 94.60 +3.8% 89.74 91.17
Share price at the end of the period in
EUR
141.10 151.35 +16.2% 132.20 130.30
Market capitalisation at the end of the
period
17,016.3 18,252.4 +16.2% 15,942.9 15,713.8
Ratios
Combined ratio (property and casualty
reinsurance) ²
96.0% 101.5% 97.9% 99.6% 101.4%
Large losses as percentage of net pre
mium earned (property and casualty
reinsurance) ³
4.2% 17.6% 8.9% 11.3% 10.9%
Retention 90.4% 88.4% 89.8% 88.6% 90.1%
Return on investment (excl. funds
withheld by ceding companies)
2.7% 3.3% 2.9% 3.0% 2.8%
EBIT margin ⁴ 8.3% 5.3% 7.3% 7.4% 5.7%
Return on equity (after tax) 12.2% 6.6% 10.2% 9.9% 8.3%

¹ Restated pursuant to IAS 8

² Including interest on funds withheld and contract deposits

³ Hannover Re Group's net share for natural catastrophes and other major losses in excess of EUR 10 million gross as a percentage of net premium earned

⁴ Operating result (EBIT)/net premium earned

Contents

Quarterly Statement
Business development
2
2
Results of operations, financial positions and net assets 3
Property and casualty reinsurance 3
Life and health reinsurance 4
Investments 5
Outlook 8
Outlook for 2021 8
Consolidated balance sheet as at 30 September 2021 10
Consolidated statement of income as at 30 September 2021 12
Consolidated statement of comprehensive income as at 30 September 2021 13
Group segment report as at 30 September 2021 14
Consolidated cash flow statement as at 30 September 2021 18
Other information 19
Contact information 20

The present document is a quarterly statement pursuant to Section 51a of the Exchange Rules or the Frankfurter Wertpapierbörse.

For further information please see the section "Other information" on page 19 of this document.

Quarterly statement as at 30 September 2021

Business development

  • Gross premium for the Group up by 14.4% adjusted for exchange rate effects
  • Property and casualty reinsurance records further vigorous growth at improved prices and conditions and major loss expenditure above expectations
  • Life and health reinsurance reports pandemic-related losses of EUR 403.5 million as at the end of September
  • Return on investment reaches 2.9% and is ahead of full-year target
  • Group net income of EUR 855.9 million still in line with expectations
  • Return on equity reaches 10.2% and thus remains above minimum target

Hannover Re can look back on a nine-month result that further underscored the resilience of its business model as a globally diversified and robustly capitalised reinsurer in a volatile market.

After major loss expenditure in property and casualty reinsurance had remained comfortably below expectations in the first half of the year, it came in significantly over budget in the third quarter. Furthermore, additional pandemic-related strains were incurred in life and health reinsurance in the third quarter. The result was also adversely affected by exchange rate losses.

These pressures were opposed by some positive effects. While the underlying property & casualty and life & health reinsurance business showed a stable development in line with expectations, the investments delivered a substantially better profit contribution than anticipated. As an additional factor, positive special effects were recorded in life and health reinsurance.

Gross written premium for the Group increased by 12.0% as at 30 September 2021 to EUR 21.6 billion (previous year: EUR: 19.3 billion). Growth would have reached 14,4 % at constant exchange rates. The retention is roughly on a par with the previous year at 89.8% (90.1%). Net premium earned increased by 11.8% to EUR 17.6 billion (EUR 15.8 billion), equivalent to growth of 13.9 % adjusted for exchange rate effects.

Investment income improved by 14.5% year-on-year to EUR 1,356.9 million (EUR 1,185.0 million). The annualised return on investment thus reached 2.9% and was above the original full-year target of around 2.4%

Other income and expenses declined by 37.4% to EUR 201.0 million (EUR 321.2 million). This was driven primarily by exchange rate losses of EUR 89 million, after gains of EUR 88 million in the previous year's period.

The operating profit (EBIT) for the Hannover Re Group improved by 41.8% to EUR 1,280.6 million (EUR 902.9 million). Group net income in the first nine months of the year grew by 28.2% to EUR 855.9 million (EUR 667.8 million). Earnings per share came in at EUR 7.10 (EUR 5.54).

Hannover Re's shareholders' equity increased to EUR 11.4 billion as at 30 September 2021 (31 December 2020: EUR 11.0 billion). The annualised return on equity amounted to 10.2% (31 December 2020: 8.3%), clearly beating the minimum target of 900 basis points above the risk-free interest rate. The book value per share thus totalled EUR 94.60 (31 December 2020: EUR 91.17).

The capital adequacy ratio at the end of September stood at 239% and was thus comfortably above our internal limit of 180% and our threshold of 200%.

In October Hannover Re also announced that it was joining the United Nations-convened Net-Zero Insurance Alliance. By committing to achieve net zero targets, Hannover Re is taking a major step towards advancing the transition to a climate-friendly economy. Among other things, we have undertaken to achieve net zero emissions in our own business operations by 2030 and in reinsurance business and investments by 2050.

.

Results of operations, financial position and net assets

Property and casualty reinsurance

  • Gross premium up by 17.7% adjusted for exchange rate effects
  • Major loss expenditure climbs to EUR 1,070.2 million after catastrophic flooding in Europe and Hurricane Ida
  • No further net strains from the Covid-19 pandemic
  • Sustained trend towards higher rates and improved conditions in treaty renewals
  • Operating profit improves on previous year by 80.3%

The third quarter in property and casualty reinsurance was impacted by large losses that clearly exceeded expectations. As a result, the total major loss budget of EUR 1.1 billion that we had calculated for the full year was already virtually exhausted by the end of September.

On the other hand, no further net strains have been incurred for Covid-19-related losses over the course of the year.

In response to the present challenges, a sustained improvement in prices and conditions can be observed across a broad front in both primary insurance and reinsurance. In this context we continue to make the profitability of the underwriting results our highest priority, also bearing in mind the protracted low interest rate environment and the sharp uptick in inflation in some areas.

The treaty renewals in property and casualty reinsurance as at 1 June and 1 July passed off correspondingly favourably for Hannover Re. It is at this time of the year that parts of the North American portfolio, some natural catastrophe risks and certain reinsurance risks in credit and surety business are renegotiated. The main renewal season also took place for business in Australia and New Zealand. On the whole, further price increases were obtained here; these were more significant for programmes or regions that had suffered losses.

Gross written premium in the Property&Casualty reinsurance business group increased by 14.4% to EUR 15.3 billion (previous year: EUR 13.3 billion). At constant exchange rates growth would have reached 17,7 %. Net premium earned improved by 14.9% to EUR 12.1 billion (EUR 10.5 billion); growth would have amounted to 17.8% adjusted for exchange rate effects.

Particularly significant drivers of the major loss expenditure in the third quarter were the flood damage in Europe and hurricane losses in the United States, although losses caused by civil unrest in South Africa and by other natural perils were also a factor here. Our net burden of large losses as at 30 September came to altogether EUR 1,070.2 million (EUR 1,149.3 million). This was considerably higher than the figure of EUR 849 million that we had budgeted for the first nine months. The largest individual losses for net account were Hurricane Ida at EUR 305.7 million, storm damage associated with the low-pressure system Bernd costing EUR 214.2 million, civil unrest in South Africa in an amount of EUR 93.8 million and flooding in China totalling EUR 34.5 million. We designate events for which we anticipate gross loss payments of more than EUR 10 million as major losses.

The underwriting result for total property and casualty reinsurance including interest on funds withheld and contract deposits stood at EUR 252.6 million (EUR -145.8 million). The combined ratio amounted to 97.9% (101.4%). While large losses took a significant toll on the result, the underlying business developed as planned and the growth booked in an attractive pricing environment continued to surpass our expectations.

The income from assets under own management booked for property and casualty reinsurance grew by 43.4 % to EUR 956.9 million (EUR 667.1 million).

The operating profit (EBIT) for the Property&Casualty reinsurance business group improved by 80.3% to EUR 1,061.2 million (EUR 588.5 million). The net income generated in property and casualty reinsurance surged by 76.8% to EUR 739.2 million (EUR 418.2 million)

Key figures for property and casualty reinsurance

in EUR million 2021 2020
1.1.–
30.6.
1.7.–
30.9.
+/–
previous
year
1.1.–
30.9.
+/–
previous
year
1.7.–
30.9.
1.1.–
30.9.
Gross written premium 10,266.5 5,002.8 +19.9% 15,269.3 +14.4% 4,173.4 13,347.6
Net premium earned 7,846.6 4,229.3 +16.1% 12,075.9 +14.9% 3,643.0 10,512.0
Net underwriting result ¹ 316.8 (64.1) 252.6 -273.3% 14.9 (145.8)
Net investment income 584.4 404.9 +62.2% 989.3 +39.7% 249.6 708.3
Operating result (EBIT) 777.9 283.3 -5.1% 1,061.2 +80.3% 298.5 588.5
Group net income 592.1 147.1 -15.2% 739.2 +76.8% 173.4 418.2
Earnings per share in EUR 4.91 1.22 -15.2% 6.13 +76.8% 1.44 3.47
EBIT margin ² 9.9% 6.7% 8.8% 8.2% 5.6%
Combined ratio ¹ 96.0% 101.5% 97.9% 99.6% 101.4%
Retention 91.3% 88.4% 90.4% 88.0% 90.3%

¹ Including interest on funds withheld and contract deposits

² Operating result (EBIT)/net premium earned

Life and health reinsurance

  • Gross premium grows by 6.9% at constant exchange rates
  • Sustained customer interest in tailor-made financial solutions and longevity covers
  • Pandemic-related losses amount to EUR 403.5 million in the first nine months
  • Operating result down by 30.2%

The Covid-19 pandemic continued to be a dominant issue in life and health reinsurance during the first nine months of the financial year, especially in the area of mortality covers. The pandemic-related strains incurred by Hannover Re in life and health reinsurance as at the end of September totalled EUR 403.5 million. Of this, the third quarter accounted for EUR 140.1 million.

The bulk of the claims relating to the Covid-19 pandemic in the first nine months were attributable – in an amount of EUR 196.6 million – to the United States, the largest market for mortality covers. South Africa, in particular, similarly saw further high pandemic-related losses in the third quarter. Overall, it remains our assumption that the expenditures will continue to diminish progressively as vaccination programmes make further progress.

As already reported, the losses incurred from the pandemic in the first quarter were offset by positive one-time income from a restructuring measure in US mortality business in an amount of EUR 129.3 million. A positive special effect of EUR 99.0 million was additionally booked in longevity business in the third quarter.

At the same time, we are benefiting from sustained brisk demand globally in financial solutions business, where we offer our clients individual reinsurance solutions designed to improve their solvency, liquidity and capital position. Similarly, we continue to see strong interest worldwide in coverage concepts for longevity risks among customers such as primary insurers and pension funds.

The gross premium volume climbed by 6.8% as at 30 September to EUR 6.4 billion (previous year: EUR 5.9 billion). Adjusted for exchange rate effects, growth stood at 6.9%. Net premium earned increased by 5.7% to EUR 5.6 billion (EUR 5.3 billion). At constant exchange rates the increase would have reached 6.0%.

The income generated for life and health reinsurance from assets under own management declined, in part due to positive one-time income recognised in the previous year, by 47.5% to EUR 184.5 million (EUR 351.7 million). The underwriting result including interest on funds withheld and contract deposits stood at EUR -315.3 million (EUR -293.2 million).

The operating result (EBIT) declined by 30.2% to EUR 220.1 million (EUR 315.5 million). The contribution made

by life and health reinsurance to Group net income fell by 49.5% to EUR 149.7 million (EUR 296.6 million).

Key figures for life and health reinsurance

in EUR million 2021 2020
1.1.– 1.7.– +/– 1.1.– +/– 1.7.– 1.1.–
30.6. 30.9. previous
year
30.9. previous
year
30.9. 30.9.
Gross written premium 4,198.1 2,152.2 +9.0% 6,350.3 +6.8% 1,975.4 5,947.3
Net premium earned 3,668.5 1,889.2 +7.9% 5,557.7 +5.7% 1,750.5 5,259.4
Investment income 280.7 86.0 -39.3% 366.6 -22.8% 141.7 474.6
Operating result (EBIT) 179.1 41.1 -59.5% 220.1 -30.2% 101.3 315.5
Net income after tax 104.8 44.9 -58.5% 149.7 -49.5% 108.2 296.6
Earnings per share in EUR 0.87 0.37 -58.5% 1.24 -49.5% 0.90 2.46
Retention 88.2% 88.4% 88.3% 89.9% 89.5%
EBIT margin ¹ 4.9% 2.2% 4.0% 5.8% 6.0%

¹ Operating result (EBIT)/net premium earned

Investments

  • Interest rates still very low after rising in the first quarter
  • Ordinary investment income up by 17.8%
  • Total investment income improves by 14.5%
  • Return on investment reaches 2.9%

The performance of our investments in the first nine months of the year was very pleasing. In addition to the ongoing pandemic, however, numerous geopolitical and economic challenges remain. On the key fixed-income markets for our company increases in the interest rate level – which in some instances were very appreciable – were observed in the first quarter for our main currency areas, especially in the longer maturity segments. Despite modest retreats subsequently recorded in some areas, the renewed rise in the interest rate level seen at the end of the third quarter was beneficial both for new investments and our reinvesting activities. Interest rates nevertheless remain very low. The same is true of risk premiums on corporate bonds.

Equity markets surged sharply higher in the first three months of the year, but increasingly tended to move sideways as the second quarter progressed. The price corrections seen by the end of the third quarter were in some instances significant. We are keeping a close eye on inflation, but currently expect the effects to be primarily of a temporary nature – such as supply chain disruptions and pent-up demand. We no longer see any appreciable implications of the pandemic's economic impacts for our investments.

Going forward, sustainability considerations will exert an even greater influence on the selection and composition of our investments. As part of our sustainability strategy, we are actively scaling back the proportion of securities whose issuers are involved in coal production and converting coal into energy. What is more, we are increasingly making sustainable infrastructure investments and investing in impact investment funds, the goal of which is to generate not only a favourable financial return but also measurably positive effects on the environment and society. In accordance with the Paris Agreement on climate change we are actively reducing the carbon intensity of our investments

Our portfolio of assets under own management grew to EUR 55.0 billion as at 30 September (31 December 2020: EUR 49.0 billion). With credit spreads only slightly narrower overall, higher interest rates led to declines in the fair values of our fixed-income securities. These were comfortably offset by positive exchange rate effects, primarily from the US dollar and pound sterling. The inflow of cash from issuance of a bond and the one-time reclassification of holdings from the technical account to investments as part of a restructuring measure in US mortality business also had favourable implications for the portfolio. Driven principally by the rise in interest rates, the unrealised gains in our fixed-income portfolio contracted to EUR 1.7 billion (31 December 2020: EUR 2.6 billion) as at the end of September.

In the first quarter we made the most of market opportunities and disposed of parts of our equity holdings. As far as fixedincome securities are concerned, we have increasingly focused our new investments and reinvestment activities throughout the year to date on instruments that offer higher returns – in due consideration of the risk profiles – relative to government bonds. We expanded our portfolio of inflation-linked bonds in response to requirements from the technical account as part of regular portfolio maintenance. Furthermore, we vigorously increased our exposure to the infrastructure and private equity segments. We significantly boosted our real estate portfolio in Asia, acting on attractive purchase opportunities in Singapore and Japan. In the area of high-yield bonds we shifted our portfolios out of fund structures and into direct investments. The modified duration of our fixed-income portfolio – at 5.7 (5.8) – was marginally reduced in comparison with the end of the previous year

Totalling EUR 1,083.2 million (EUR 919.4 million), it is pleasing to note that the ordinary investment income excluding interest on funds withheld and contract deposits came in comfortably above the level of the previous year's period and even exceeded our expectations. Ordinary income from fixed-income securities and the real estate sector was considerably higher than in the comparable period. Considerably stronger earnings from our portfolio of inflation-linked bonds, which we hold to limit possible inflation risks, were also a factor here. In addition, we generated very appreciable increases in income booked from alternative investment funds. Interest on funds withheld and contract deposits also came in sharply higher at EUR 214.5 million (EUR 164.1 million).

The net balance of gains realised on disposals amounted to EUR 237.6 million (EUR 192.1 million), primarily reflecting regrouping moves as part of portfolio maintenance and restructuring as well as the aforementioned share sales. In the United States we successfully made the most of conditions on the real estate market by selling a large property. We were also able to realise pleasing gains in connection with the realignment of our high-yield holdings noted above. Impairments of altogether EUR 51.8 were recognised; this amount is significantly lower than in the first three quarters of the previous year (EUR 101.6 million), which was clearly affected by the emerging economic impacts of the Covid-19 pandemic. Of this, EUR 16.0 million (EUR 50.3 million) was attributable to alternative investments and EUR 7.1 million (EUR 11.8 million) to real estate funds. Fixed-income securities accounted for EUR 0.2 million (EUR 11.8 million). The depreciation recognised on directly held real estate was stable at EUR 27.9 million (EUR 27.3 million).

We recognise a derivative for the credit risk associated with special life reinsurance treaties (ModCo) under which securities deposits are held by cedants for our account; the performance of this derivative in the period under review gave rise to unrealised losses of EUR 14.9 million (EUR -8.7 million) recognised in income. In economic terms we assume a neutral development for this item over time, and hence the volatility that can occur in specific quarters provides no insight into the actual business development. Altogether, the unrealised losses in our assets recognised at fair value through profit or loss amounted to EUR 48.5 million (gains of EUR 41.4 million). The key driver here was the performance of a derivative relating to the technical account.

The investment income of EUR 1,356.9 million (EUR 1,185.0 million) improved on the level of the comparable period despite negative changes in the fair values of assets recognised at fair value through profit or loss. Income from assets under own management accounted for EUR 1,142.4 million (EUR 1,020.9 million), producing an annualised average return (including effects from derivatives) of 2.9%.

Net investment income

in EUR million 2021 2020
1.1.–
30.6.
1.7.–
30.9.
+/–
previous
1.1.–
30.9.
+/–
previous
1.7.–
30.9.
1.1.–
30.9.
Ordinary investment income ¹ 681.7 401.5 year
+28.8%
1,083.2 year
+17.8%
311.7 919.4
Result from participations in associated com
panies
16.0 6.6 -88.8% 22.6 -65.3% 58.6 65.0
Realised gains/losses 142.0 95.6 +83.0% 237.6 +23.7% 52.2 192.1
Appreciation ² 38.4 13.4 -18.7% 51.8 -49.0% 16.5 101.6
Change in fair value of financial instruments ³ (43.1) (5.3) -42.1% (48.5) -216.9% (9.2) 41.4
Investment expenses 64.6 36.2 +10.5% 100.8 +5.6% 32.8 95.4
Net investment income from assets under own
management
693.7 448.7 +23.2% 1,142.4 +11.9% 364.1 1,020.9
Net investment income from funds withheld 172.2 42.4 +52.5% 214.5 +30.8% 27.8 164.1
Total investment income 865.8 491.1 +25.3% 1,356.9 +14.5% 391.9 1,185.0

¹ Excluding interest on funds withheld and contract deposits

² Including depreciation/impairments on real estate

³ Portfolio at fair value through profit or loss and trading

Outlook

  • Gross premium for the Group expected to show growth at least in the upper single-digit percentages adjusted for exchange rate effects
  • Return on investment should beat the 2.4% mark after good nine-month result
  • Group net income guidance of EUR 1.15 billion to EUR 1.25 billion for 2021 confirmed

The Covid-19 pandemic continues to set the tone on global reinsurance markets in the current financial year. In property and casualty reinsurance, however, it is our assumption that the pandemic-related net reserves established in 2020 are still adequate overall. Following the considerable major losses incurred in the third quarter, the goal of a combined ratio of 96% or better is no longer attainable in this financial year if large losses in the fourth quarter come in around the budgeted level. The successful treaty renewals have to some extent already made themselves felt in improved profitability prospects in the current financial year and will continue to do so in subsequent years.

In life and health reinsurance, the future pandemic-related loss experience will be dependent on the success of ongoing vaccination campaigns and containment efforts around the world as well as the emergence of virus variants. On the whole, it remains our expectation that the strains will continue to diminish progressively as vaccination programmes make further progress.

Following the good performance in the first nine months, we now expect a return on investment of more than 2.4% for the current financial year. The growth in Group gross premium should be at least in the upper single-digit percentages adjusted for exchange rate effects.

Even after the heavy losses of the third quarter, we consider ourselves well placed in relation to our 2021 full-year guidance, which we still expect to achieve. On the Group level our expectation of net income between EUR 1.15 billion and EUR 1.25 billion for the 2021 financial year remains unchanged. Achievement of the earnings target is dependent on major loss expenditure not significantly exceeding the budgeted level for the fourth quarter of EUR 251 million and assumes that there are no Covid-19-related losses substantially above expectations in life and health reinsurance and no unforeseen distortions on capital markets.

The capital adequacy ratio at the end of the year should remain comfortably above our limit of 180% and our threshold of 200%.

Going forward, Hannover Re intends to place even greater emphasis on the continuity of its dividend payments. From the current financial year onwards, the ordinary dividend will at least be on the level of the previous year. This means that a practice already followed at our company over the past ten years has now been enshrined as a policy – one made possible by the resilience of our business model as a globally diversified and robustly capitalised reinsurer. The ordinary dividend will be supplemented by payment of a special dividend provided the capitalisation exceeds the capital required for future growth and the profit target is achieved.

Outlook for 2022

For the 2022 financial year Hannover Re anticipates Group net income of EUR 1.4 billion to EUR 1.5 billion. In addition, we expect a return on investment of at least 2.3% and growth of at least 5% in Group gross premium adjusted for exchange rate effects.

The expectations for 2022 additionally reflect an increase in the net major loss budget to EUR 1.3 billion (EUR 1.1 billion) that is commensurate with the growth in the underlying business.

As usual, all forward-looking statements regarding future targets are based on the premise that there are no unforeseen distortions on capital markets, that major loss expenditure remains within the budgeted level and that the Covid-19 pandemic does not significantly affect the result in life and health reinsurance.

Consolidated balance sheet as at 30 September 2021

in EUR thousand 30.9.2021 31.12.2020 ¹
Fixed-income securities - held to maturity 71,782 185,577
Fixed-income securities - loans and receivables 2,377,690 2,312,840
Fixed-income securities - available for sale 43,668,290 38,851,723
Fixed-income securities - at fair value through profit or loss 73,405 105,711
Equity securities - available for sale 293,059 378,422
Other financial assets - at fair value through profit or loss 190,450 234,689
Investment property 1,856,959 1,589,238
Real estate funds 731,556 582,296
Investments in associated companies 383,514 361,617
Other invested assets 3,202,966 2,794,016
Short-term investments 493,024 327,426
Cash and cash equivalents 1,687,226 1,278,071
Total investments and cash under own management 55,029,921 49,001,626
Funds withheld 10,894,478 9,659,807
Contract deposits 408,915 298,344
Total investments 66,333,314 58,959,777
Reinsurance recoverables on unpaid claims 2,543,288 1,883,270
Reinsurance recoverables on benefit reserve 180,588 192,135
Prepaid reinsurance premium 308,846 165,916
Reinsurance recoverables on other technical reserves 1,782 1,106
Deferred acquisition costs 3,580,679 3,073,117
Accounts receivable 7,368,552 5,605,803
Goodwill 83,063 80,965
Deferred tax assets 510,038 597,986
Other assets 859,641 859,136
Accrued interest and rent 18,373 18,264
Total assets 81,788,164 71,437,475

¹ Restated pursuant to IAS 8

Liabilities
in EUR thousand 30.9.2021 31.12.2020 ¹
Loss and loss adjustment expense reserve 39,082,146 33,929,230
Benefit reserve 7,373,009 7,217,988
Unearned premium reserve 7,235,633 5,070,009
Other technical provisions 750,740 701,577
Funds withheld 671,140 582,316
Contract deposits 3,612,995 3,255,453
Reinsurance payable 2,415,394 1,777,761
Provisions for pensions 204,597 229,252
Taxes 168,141 132,736
Deferred tax liabilities 2,752,146 2,731,648
Other liabilities 910,727 538,813
Financing liabilities 4,350,780 3,431,276
Total liabilities 69,527,448 59,598,059
Shareholders' equity
Common shares 120,597 120,597
Nominal value: 120,597 Conditional capital: 24,119
Additional paid-in capital 724,562 724,562
Common shares and additional paid-in capital 845,159 845,159
Cumulative other comprehensive income
Unrealised gains and losses on investments 1,867,810 2,275,936
Cumulative foreign currency translation adjustment 163,279 (330,693)
Changes from hedging instruments (8,459) (8,678)
Other changes in cumulative other comprehensive income (69,511) (83,792)
Total other comprehensive income 1,953,119 1,852,773
Retained earnings 8,610,709 8,297,114
Equity attributable to shareholders of Hannover Rück SE 11,408,987 10,995,046
Non-controlling interests 851,729 844,370
Total shareholders' equity 12,260,716 11,839,416
Total liabilities 81,788,164 71,437,475

¹ Restated pursuant to IAS 8

Consolidated statement of income as at 30 September 2021

Gross written premium
7,155,047
21,619,646
6,148,779 19,294,915
Ceded written premium
827,680
2,212,223
700,118 1,913,861
Change in gross unearned premium
(243,350)
(1,905,724)
(140,751) (1,769,454)
Change in ceded unearned premium
34,539
132,155
85,661 160,055
Net premium earned
6,118,556
17,633,854
5,393,571 15,771,655
Ordinary investment income
401,511
1,083,212
311,748 919,409
Profit / loss from investments in associated compa
nies
6,565
22,584
58,580 65,011
Realised gains and losses on investments
95,622
237,643
52,248 192,073
Change in fair value of financial instruments
(5,329)
(48,470)
(9,199) 41,449
Total depreciation, impairments and appreciation of
investments
13,385
51,757
16,471 101,572
Other investment expenses
36,245
100,823
32,787 95,446
Net income from investments under own man
agement
448,739
1,142,389
364,119 1,020,924
Income / expense on funds withheld and contract
deposits
42,359
214,510
27,782 164,060
Net investment income
491,098
1,356,899
391,901 1,184,984
Other technical income

112
Total revenues
6,609,654
18,990,865
5,785,472 16,956,639
Claims and claims expenses
4,988,467
13,619,006
4,190,882 12,389,179
Change in benefit reserves
(144,949)
(258,450)
(23,117) (168,599)
Commission and brokerage, change in deferred ac
quisition costs
1,378,443
4,164,024
1,256,928 3,803,522
Other acquisition costs
865
3,108
962 3,338
Administrative expenses
125,121
383,556
104,575 347,519
Total technical expenses
6,347,947
17,911,244
5,530,230 16,374,959
Other income
155,115
551,296
213,648 613,628
Other expenses
92,289
350,277
69,548 292,457
Other income and expenses
62,826
201,019
144,100 321,171
Operating profit / loss (EBIT)
324,533
1,280,640
399,342 902,851
Financing costs
21,307
61,432
24,449 71,553
Net income before taxes
303,226
1,219,208
374,893 831,298
Taxes
106,053
318,198
90,327 141,791
Net income
197,173
901,010
284,566 689,507
thereof
Non-controlling interest in profit and loss
11,806
45,091
19,106 21,695
Group net income
185,367
855,919
265,460 667,812
Earnings per share (in EUR)
Basic earnings per share
1.54
7.10
2.20 5.54
Diluted earnings per share
1.54
7.10
2.20 5.54

Consolidated statement of comprehensive income as at 30 September 2021

in EUR thousand 1.7. -
30.9.2021
1.1. -
30.9.2021
1.7. -
30.9.2020
1.1. -
30.9.2020
Net income 197,173 901,010 284,566 689,507
Not reclassifiable to the consolidated statement of income
Actuarial gains and losses
Gains (losses) recognised directly in equity 4,852 23,367 (12,166) (7,782)
Tax income (expense) (1,579) (7,620) 3,971 2,553
3,273 15,747 (8,195) (5,229)
Changes from the measurement of associated companies
Gains (losses) recognised directly in equity 32 166 (61) (39)
32 166 (61) (39)
Income and expense recognised directly in equity that cannot be re
classified
Gains (losses) recognised directly in equity 4,884 23,533 (12,227) (7,821)
Tax income (expense) (1,579) (7,620) 3,971 2,553
3,305 15,913 (8,256) (5,268)
Reclassifiable to the consolidated statement of income
Unrealised gains and losses on investments
Gains (losses) recognised directly in equity 34,973 (383,499) 319,860 1,048,515
Transferred to the consolidated statement of income (93,843) (222,661) (38,544) (104,596)
Tax income (expense) 44,775 198,178 (69,875) (196,096)
(14,095) (407,982) 211,441 747,823
Currency translation
Gains (losses) recognised directly in equity 211,486 566,597 (350,957) (480,423)
Tax income (expense) (19,744) (65,582) 31,942 51,955
191,742 501,015 (319,015) (428,468)
Changes from the measurement of associated companies
Gains (losses) recognised directly in equity (1,829) (1,884) (2,151) (2,117)
(1,829) (1,884) (2,151) (2,117)
Changes from hedging instruments
Gains (losses) recognised directly in equity 2,889 491 (3,620) (7,787)
Tax income (expense) (640) (252) 948 2,879
2,249 239 (2,672) (4,908)
Reclassifiable income and expense recognised directly in equity
Gains (losses) recognised directly in equity 247,519 181,706 (36,868) 558,188
Transferred to the consolidated statement of income (93,844) (222,661) (38,544) (104,596)
Tax income (expense) 24,391 132,344 (36,985) (141,262)
178,067 91,388 (112,397) 312,330
Total income and expense recognised directly in equity
Gains (losses) recognised directly in equity 252,403 205,238 (49,095) 550,367
Transferred to the consolidated statement of income (93,844) (222,661) (38,544) (104,596)
Tax income (expense) 22,812 124,724 (33,014) (138,709)
181,372 107,301 (120,653) 307,062
Total recognised income and expense 378,545 1,008,311 163,913 996,569
thereof
Attributable to non-controlling interests 20,052 52,046 28,898 38,605
Attributable to shareholders of Hannover Rück SE 358,493 956,265 135,015 957,964

Group segment report as at 30 September 2021

Segmentation of assets Property and casualty reinsurance
in EUR thousand 30.9.2021 31.12.2020 ¹
Assets
Fixed-income securities - held to maturity 64,641 139,867
Fixed-income securities - loans and receivables 1,907,425 1,998,611
Fixed-income securities - available for sale 33,352,259 29,422,685
Equity securities - available for sale 293,059 378,422
Financial assets at fair value through profit or loss 76,806 110,304
Other invested assets 5,253,599 4,384,139
Short-term investments 316,222 244,474
Cash 1,254,464 901,989
Total investments and cash under own management 42,518,475 37,580,491
Funds withheld 3,526,979 2,569,420
Contract deposits 5,943 5,404
Total investments 46,051,397 40,155,315
Reinsurance recoverables on unpaid claims 2,392,769 1,730,507
Reinsurance recoverables on benefit reserve
Prepaid reinsurance premium 308,732 165,834
Reinsurance recoverables on other reserves 555 562
Deferred acquisition costs 1,700,724 1,169,521
Accounts receivable 5,823,361 4,155,372
Other assets in the segment 3,178,961 2,788,243
Total assets 59,456,499 50,165,354

Segmentation of liabilities

in EUR thousand
Liabilities
Loss and loss adjustment expense reserve 33,668,219 29,194,354
Benefit reserve
Unearned premium reserve 6,808,309 4,709,229
Provisions for contingent commissions 440,695 395,296
Funds withheld 413,578 342,420
Contract deposits 82,270 80,369
Reinsurance payable 1,747,768 1,157,650
Financing liabilities 596,192 420,348
Other liabilities in the segment 2,696,921 2,478,161
Total liabilities 46,453,952 38,777,827

¹ Restated pursuant to IAS 8

Life and health reinsurance Consolidation Total
30.9.2021 31.12.2020 ¹ 30.9.2021 31.12.2020 ¹ 30.9.2021 31.12.2020 ¹
7,141 45,710 71,782 185,577
454,543 299,180 15,722 15,049 2,377,690 2,312,840
10,296,800 9,429,038 19,231 43,668,290 38,851,723
293,059 378,422
187,049 230,096 263,855 340,400
917,732 920,960 3,664 22,068 6,174,995 5,327,167
176,611 82,221 191 731 493,024 327,426
428,319 371,972 4,443 4,110 1,687,226 1,278,071
12,468,195 11,379,177 43,251 41,958 55,029,921 49,001,626
7,367,499 7,090,387 10,894,478 9,659,807
402,972 292,940 408,915 298,344
20,238,666 18,762,504 43,251 41,958 66,333,314 58,959,777
150,519 152,763 2,543,288 1,883,270
180,588 192,135 180,588 192,135
199 82 (85) 308,846 165,916
1,227 544 1,782 1,106
1,879,955 1,903,596 3,580,679 3,073,117
1,545,191 1,450,628 (197) 7,368,552 5,605,803
540,806 470,282 (2,248,652) (1,702,174) 1,471,115 1,556,351
24,537,151 22,932,534 (2,205,486) (1,660,413) 81,788,164 71,437,475
5,413,927 4,734,876 39,082,146 33,929,230
7,373,009 7,217,988 7,373,009 7,217,988
427,324 360,780 7,235,633 5,070,009
310,045 306,281 750,740 701,577
257,562 239,896 671,140 582,316
3,530,725 3,175,084 3,612,995 3,255,453
667,966 620,111 (340) 2,415,394 1,777,761
32,217 35,010 3,722,371 2,975,918 4,350,780 3,431,276
3,586,860 2,863,934 (2,248,170) (1,709,646) 4,035,611 3,632,449
21,599,635 19,553,960 1,473,861 1,266,272 69,527,448 59,598,059
Segment statement of income Property and casualty reinsurance
in EUR thousand 1.1. - 30.9.2021 1.1. - 30.9.2020
Gross written premium 15,269,339 13,347,606
Net premium earned 12,075,930 10,512,041
Net investment income 989,295 708,252
thereof
Change in fair value of financial instruments 4,089 1,095
Total depreciation, impairments and appreciation of investments 51,734 99,761
Income / expense on funds withheld and contract deposits 32,390 41,111
Claims and claims expenses 8,436,706 7,658,185
Change in benefit reserve
Commission and brokerage, change in deferred acquisition costs and other technical in
come / expenses
3,233,639 2,881,802
Administrative expenses 185,354 158,947
Other income and expenses (148,360) 67,161
Operating profit / loss (EBIT) 1,061,166 588,520
Financing costs 1,545 1,576
Net income before taxes 1,059,621 586,944
Taxes 276,043 148,079
Net income 783,578 438,865
thereof
Non-controlling interest in profit or loss 44,342 20,687
Group net income 739,236 418,178
Life and health reinsurance Consolidation Total
1.1. - 30.9.2021 1.1. - 30.9.2020 1.1. - 30.9.2021 1.1. - 30.9.2020 1.1. - 30.9.2021 1.1. - 30.9.2020
6,350,307 5,947,309 21,619,646 19,294,915
5,557,677 5,259,442 247 172 17,633,854 15,771,655
366,635 474,614 969 2,118 1,356,899 1,184,984
(52,559) 40,354 (48,470) 41,449
23 1,811 51,757 101,572
182,120 122,949 214,510 164,060
5,182,300 4,730,994 13,619,006 12,389,179
(258,450) (168,599) (258,450) (168,599)
933,381 925,058 4,167,020 3,806,860
197,855 188,178 347 394 383,556 347,519
350,890 257,031 (1,511) (3,021) 201,019 321,171
220,116 315,456 (642) (1,125) 1,280,640 902,851
1,137 1,097 58,750 68,880 61,432 71,553
218,979 314,359 (59,392) (70,005) 1,219,208 831,298
68,531 16,765 (26,376) (23,053) 318,198 141,791
150,448 297,594 (33,016) (46,952) 901,010 689,507
749 1,008 45,091 21,695
149,699 296,586 (33,016) (46,952) 855,919 667,812

Consolidated cash flow statement as at 30 September 2021

in EUR thousand 1.1. - 30.9.2021 1.1. - 30.9.2020
I. Cash flow from operating activities
Net income 901,010 689,507
Appreciation / depreciation 87,597 116,437
Realised gains and losses on investments (237,643) (192,073)
Change in fair value of financial instruments (through profit or loss) 48,470 (41,449)
Amortisation 15,856 67,312
Changes in funds withheld (763,800) (780,265)
Net changes in contract deposits 125,512 (99,130)
Changes in prepaid reinsurance premium 1,773,637 1,609,399
Change in tax assets / provisions for taxes 277,048 (73,016)
Change in benefit reserve (140,463) (318,596)
Change in claims reserves 3,289,123 2,414,399
Change in deferred acquisition costs (408,867) (204,436)
Change in other technical provisions 25,924 60,746
Change in accounts receivable / payable (1,006,611) (526,582)
Change in other assets and liabilities 206,041 (132,616)
Cash flow from operating activities 4,192,834 2,589,637
II. Cash flow from investing activities (4,147,411) (1,555,183)
III. Cash flow from financing activities 300,578 (725,819)
IV. Exchange rate differences on cash 63,154 (55,117)
Cash and cash equivalents at the beginning of the period 1,278,071 1,090,852
Change in cash and cash equivalents (I. + II. + III. + IV.) 409,155 253,518
Cash and cash equivalents at the end of the period 1,687,226 1,344,370
Supplementary information on the cash flow statement ¹
Income taxes paid (on balance) (53,670) (202,013)
Dividend receipts ² 217,721 101,217
Interest received 1,198,427 1,160,044
Interest paid (315,083) (225,304)

¹ The income taxes paid, dividend receipts as well as interest received and paid are included entirely in the cash flow from operating activities.

² Including dividend-like profit participations from investment funds

Other information

The present document is a quarterly statement pursuant to Section 51a of the Exchange Rules for the Frankfurter Wertpapierbörse (BörsO FWB). It was drawn up according to the International Financial Reporting Standards (IFRS) that are to be applied within the European Union, but does not constitute an interim financial report as defined by IAS 34 "Interim Financial Reporting" or a financial statement as defined by IAS 1 "Presentation of Financial Statements". In view of the Covid-19 pandemic, estimates are subject to a higher degree of uncertainty and greater use was therefore made of scenario calculations.

The accounting policies are essentially the same as those applied in the consolidated financial statement as at 31 December 2020. In the 2021 financial year a number of amendments to existing standards and interpretations were issued with no significant implications for the consolidated financial statement:

  • Amendments to IFRS 16 Leases: Covid-19-Related Rent Concessions beyond 30 June 2021
  • Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 Interest Rate Benchmark Reform – Phase 2
  • Amendments to IFRS4 Insurance Contracts deferral of IFRS 9

Hannover Re is exercising the temporary exemption from applying IFRS 9 "Financial Instruments" that is available to companies whose activities are predominantly connected with insurance.

Contact information

Corporate Communications

Karl Steinle Tel. + 49 511 5604-1500 Fax + 49 511 5604-1648 [email protected]

Media Relations

Oliver Süß Tel. + 49 511 5604-1502 Fax + 49 511 5604-1648 [email protected]

Investor Relations

Axel Bock Tel. + 49 511 5604-1736 Fax + 49 511 5604-1648 [email protected]

Published by

Hannover Rück SE Karl-Wiechert-Allee 50 30625 Hannover, Germany Tel. + 49 511 5604-0 Fax + 49 511 5604-1188

www.hannover-re.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.